Dr. Cavazzone
The FDA must act with more forethought and expediency to approve drugs for ALS. Your actions are not consistent with the words you speak. People with ALS are suffering and dying while being denied access to potentially helpful drugs that have been proven safe.
The US should lead the world with its compassion care and understanding of complex diseases and expedite potential treatments.
FDA lead from the frontlines of the battle.
David L. MD